Pharmaceutical Preparations companies: boards of directors (SIC 2834)
- Organizations
- 475
- Directors
- 3,605
- Average board size
- 9.4
| Organization | Directors | CEO |
|---|---|---|
| Immuneering Corporation Nasdaq: IMRX · Cambridge, United States | 7 | Benjamin J. Zeskind |
| InflaRx N.V. Nasdaq: IFRX · Jena, Germany | 7 | Niels Riedemann |
| InMed Pharmaceuticals Inc. Nasdaq: INM · Vancouver, Canada | 7 | Eric A. Adams |
| Journey Medical Corporation Nasdaq: DERM · Scottsdale, United States | 7 | Claude Maraoui |
| Larimar Therapeutics Inc. Nasdaq: LRMR · Bala Cynwyd, United States | 7 | Carole Ben-Maimon |
| Latigo Biotherapeutics Inc. Nasdaq: LTGO · Thousand Oaks, United States | 7 | Nima Farzan |
| Lipocine Inc. Nasdaq: LPCN · Salt Lake City, United States | 7 | Mahesh Patel V |
| Minerva Neurosciences Inc Nasdaq: NERV · Burlington, United States | 7 | Remy Luthringer |
| MoonLake Immunotherapeutics Nasdaq: MLTX · ZUG, United States | 7 | Da Silva Jorge Santos |
| Mustang Bio Inc. Nasdaq: MBIO · Waltham, United States | 7 | Manuel Litchman M.D. |
| Nasus Pharma Ltd. NYSE American: NSRX · TEL Aviv - Yafo | 7 | Brendan P. O'Grady |
| Nektar Therapeutics Nasdaq: NKTR · SAN Francisco, United States | 7 | Howard W. Robin |
| NewcelX Ltd. Nasdaq: NCEL · Zurich, Switzerland | 7 | Ronen Twito |
| Palatin Technologies Inc. Nasdaq: PTN · Cranbury, United States | 7 | Carl Spana |
| Perspective Therapeutics Inc. NYSE American: CATX · Seattle, United States | 7 | Johan M. Spoor |
| Quoin Pharmaceuticals Ltd. Nasdaq: QNRX · Ashburn, Israel | 7 | Michael Myers |
| Rezolute Inc. Nasdaq: RZLT · Redwood City, United States | 7 | Nevan C. Elam |
| Savara Inc. Nasdaq: SVRA · Austin, United States | 7 | Matthew Pauls |
| SciSparc Ltd. Nasdaq: SPRC · TEL Aviv, Israel | 7 | — |
| Silence Therapeutics Plc American Depository Share Nasdaq: SLN · London, United Kingdom | 7 | Craig A. Tooman |
| Supernus Pharmaceuticals Inc. Nasdaq: SUPN · Rockville, United States | 7 | Jack A. Khattar |
| Telix Pharmaceuticals Limited Nasdaq: TLX · North Melbourne, Australia | 7 | Christian Behrenbruch |
| Tenax Therapeutics Inc. Nasdaq: TENX · Chapel Hill, United States | 7 | Christopher Thomas Giordano |
| TransCode Therapeutics Inc. Nasdaq: RNAZ · Boston, United States | 7 | Robert Michael Dudley |
| Trevi Therapeutics Inc. Nasdaq: TRVI · New Haven, United States | 7 | Jennifer L. Good |
| Unicycive Therapeutics Inc. Nasdaq: UNCY · Mountain View, United States | 7 | Shalabh K. Gupta |
| Upstream Bio Inc. Nasdaq: UPB · Waltham, United States | 7 | Everett Rand Sutherland |
| Vanda Pharmaceuticals Inc. Nasdaq: VNDA · Washington, United States | 7 | Mihael Hristos Polymeropoulos |
| Veru Inc. Nasdaq: VERU · Miami, United States | 7 | Mitchell Shuster Steiner |
| Viking Therapeutics Inc. Nasdaq: VKTX · SAN Diego, United States | 7 | Brian Lian |
| Vogenx Inc Nasdaq: VOGX · Raleigh, United States | 7 | James Green |
| 60 Degrees Pharmaceuticals Inc. Nasdaq: SXTP · Washington, United States | 6 | Geoffrey S. Dow |
| Aardvark Therapeutics Inc. Nasdaq: AARD · SAN Diego, United States | 6 | Tien-Li Lee |
| Actinium Pharmaceuticals Inc. (Delaware) NYSE American: ATNM · New York, United States | 6 | Sandesh Seth |
| Adagene Inc. Nasdaq: ADAG · Jiangsu, China | 6 | Peter Luo |
| ADARx Pharmaceuticals Inc. Nasdaq: ADRX · SAN Diego, United States | 6 | Zhen Li |
| Addex Therapeutics Ltd Nasdaq: ADXN · Geneva, Switzerland | 6 | Timothy Mark Dyer |
| Atrium Therapeutics Inc. Nasdaq: RNA · SAN Diego, United States | 6 | — |
| BeyondSpring Inc. Nasdaq: BYSI · Florham Park, United States | 6 | Lan Huang |
| Biodexa Pharmaceuticals plc American Depositary Shs Nasdaq: BDRX · Cardiff, United Kingdom | 6 | Stephen Anthony Stamp |
| Biofrontera Inc. Nasdaq: BFRI · Woburn, United States | 6 | Hermann Luebbert |
| Cadrenal Therapeutics Inc. Nasdaq: CVKD · Ponte Vedra, United States | 6 | Quang X. Pham |
| City Therapeutics Inc. Nasdaq: CTY · Cambridge, United States | 6 | Andrew C. Orth |
| Connect Biopharma Holdings Limited Nasdaq: CNTB · SAN Diego, China | 6 | Barry D. Quart |
| Enveric Biosciences Inc. Nasdaq: ENVB · Cambridge, United States | 6 | Joseph Edward Tucker |
| Genelux Corporation Nasdaq: GNLX · Westlake Village, United States | 6 | Thomas Zindrick |
| Lantern Pharma Inc. Nasdaq: LTRN · Dallas, United States | 6 | Panna Sharma |
| Marker Therapeutics Inc. Nasdaq: MRKR · Houston, United States | 6 | Juan Vera |
| Moleculin Biotech Inc. Nasdaq: MBRX · Houston, United States | 6 | Walter Klemp V |
| Neuphoria Therapeutics Inc. Nasdaq: NEUP · Burlington, United States | 6 | Spyros Papapetropoulos |
Organizations whose headquarters, sector or industry code is on file and that have at least one current director. Sectors not on file are derived from the industry code (an approximate match to GICS). Board sizes count every current seat on record; see where our data comes from.